Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.900
-0.060 (-2.03%)
At close: May 30, 2025, 4:00 PM
3.040
+0.140 (4.83%)
After-hours: May 30, 2025, 4:02 PM EDT

Kalaris Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
100.971.643.173.06
Cash & Short-Term Investments
100.971.643.173.06
Cash Growth
3200.59%-48.28%3.60%-
Prepaid Expenses
1.220.970.160.84
Total Current Assets
102.182.613.333.9
Long-Term Deferred Charges
-3.15--
Other Long-Term Assets
0.910.41--
Total Assets
103.096.163.333.9
Accounts Payable
2.371.562.362.75
Accrued Expenses
4.542.1312.52
Short-Term Debt
-19.91--
Other Current Liabilities
0.231.110.580.42
Total Current Liabilities
7.1424.73.945.69
Long-Term Debt
---3.25
Other Long-Term Liabilities
32.0832.08-0.26
Total Liabilities
39.2256.783.949.21
Additional Paid-In Capital
190.6319.952.382.42
Retained Earnings
-126.76-116.56-47.39-32.7
Total Common Equity
63.87-96.62-45.02-30.27
Shareholders' Equity
63.87-50.62-0.61-5.31
Total Liabilities & Equity
103.096.163.333.9
Total Debt
-19.91-3.25
Net Cash (Debt)
100.97-18.273.17-0.19
Net Cash Per Share
13.81-2.760.52-0.04
Filing Date Shares Outstanding
18.718.76.764.44
Total Common Shares Outstanding
18.76.736.764.44
Working Capital
95.04-22.1-0.61-1.79
Book Value Per Share
3.42-14.36-6.66-6.81
Tangible Book Value
63.87-96.62-45.02-30.27
Tangible Book Value Per Share
3.42-14.36-6.66-6.81
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.